INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 273 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,138,323 | -18.5% | 3,170,250 | -1.0% | 2.66% | -8.0% |
| Q2 2023 | $202,737,976 | +14.6% | 3,201,800 | -2.0% | 2.89% | +12.6% |
| Q1 2023 | $176,962,200 | +0.1% | 3,268,000 | -2.2% | 2.57% | +9.4% |
| Q4 2022 | $176,871,129 | +14.2% | 3,342,236 | +0.4% | 2.35% | +5.6% |
| Q3 2022 | $154,912,000 | -19.0% | 3,329,279 | -0.6% | 2.22% | -17.8% |
| Q2 2022 | $191,183,000 | -8.9% | 3,349,379 | -2.3% | 2.70% | +10.9% |
| Q1 2022 | $209,859,000 | +10.5% | 3,429,619 | -5.5% | 2.44% | +24.5% |
| Q4 2021 | $189,938,000 | +35.0% | 3,628,919 | -3.8% | 1.96% | +37.1% |
| Q3 2021 | $140,691,000 | -4.5% | 3,773,919 | +4.5% | 1.43% | -0.7% |
| Q2 2021 | $147,357,000 | +18.7% | 3,609,919 | -1.4% | 1.44% | +9.4% |
| Q1 2021 | $124,181,000 | +6.7% | 3,659,919 | 0.0% | 1.31% | -1.4% |
| Q4 2020 | $116,386,000 | +26.7% | 3,659,919 | +2.2% | 1.33% | +5.0% |
| Q3 2020 | $91,861,000 | -5.3% | 3,579,919 | -5.3% | 1.27% | -7.6% |
| Q2 2020 | $97,031,000 | +69.2% | 3,779,919 | +1.3% | 1.37% | +23.5% |
| Q1 2020 | $57,358,000 | -29.3% | 3,731,819 | +57.7% | 1.11% | -13.6% |
| Q4 2019 | $81,177,000 | +319.7% | 2,366,000 | -8.6% | 1.29% | +257.5% |
| Q3 2019 | $19,340,000 | -33.6% | 2,588,990 | +15.3% | 0.36% | -27.7% |
| Q2 2019 | $29,147,000 | +4765.9% | 2,245,500 | +4169.0% | 0.50% | +1176.9% |
| Q4 2018 | $599,000 | -49.5% | 52,600 | -3.7% | 0.04% | -48.0% |
| Q3 2018 | $1,185,000 | -16.1% | 54,600 | -31.7% | 0.08% | -37.5% |
| Q2 2018 | $1,412,000 | -26.3% | 79,900 | -12.2% | 0.12% | -36.8% |
| Q1 2018 | $1,916,000 | +43.1% | 91,000 | -1.6% | 0.19% | +35.7% |
| Q4 2017 | $1,339,000 | +112.2% | 92,500 | +131.2% | 0.14% | +112.1% |
| Q3 2017 | $631,000 | +27.0% | 40,000 | 0.0% | 0.07% | +11.9% |
| Q2 2017 | $497,000 | – | 40,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |